United States · FDA National Drug Code directory
HEPCLUDEX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61958-3104_11157b93-ad66-4935-8d4a-b0829c809187
- Product NDC
- 61958-3104
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- BULEVIRTIDE
- Labeler
- Gilead Sciences, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260522
- Source listing expiry
- 20271231
Source-listed ingredients
- BULEVIRTIDE ACETATE — 8.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 VIAL, SINGLE-DOSE in 1 CARTON (61958-3104-1) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (61958-3104-2) · 61958-3104-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →